Justin Bowers
Stock Analyst at Deutsche Bank
(2.52)
# 2,326
Out of 4,761 analysts
49
Total ratings
41.94%
Success rate
5.07%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $374.82 | -13.29% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $191.04 | +38.71% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $14.88 | +54.57% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.96 | +26.31% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $90.44 | +11.68% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $340.22 | -1.24% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $10.90 | +129.36% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $158.99 | -2.51% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $532.55 | +14.54% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $64.92 | +26.31% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $17.30 | +44.51% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $4.11 | +313.63% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $201.39 | +48.96% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $210.23 | +30.81% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $210.91 | +18.53% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $163.02 | +77.89% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $17.68 | +160.18% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $374.82
Upside: -13.29%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $191.04
Upside: +38.71%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $14.88
Upside: +54.57%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.96
Upside: +26.31%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $90.44
Upside: +11.68%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $340.22
Upside: -1.24%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $10.90
Upside: +129.36%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $158.99
Upside: -2.51%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $532.55
Upside: +14.54%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $64.92
Upside: +26.31%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $17.30
Upside: +44.51%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $4.11
Upside: +313.63%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $201.39
Upside: +48.96%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $210.23
Upside: +30.81%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $210.91
Upside: +18.53%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $163.02
Upside: +77.89%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $17.68
Upside: +160.18%